Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
The impact of obesity on survival is known to vary in different cancers. Advanced biliary tract cancer was rarely analyzed about the relationship between obesity and prognosis. We performed this study to evaluate the BMI and body weight change as prognostic factors for advanced biliary tract cancer...
Main Authors: | Jinwoo Kang, Sang Hyub Lee, Jun Hyuk Son, Jae Woo Lee, Young Hoon Choi, Jin Ho Choi, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5880377?pdf=render |
Similar Items
-
Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer.
by: Jaihwan Kim, et al.
Published: (2018-01-01) -
Chemotherapy for Biliary Tract Cancer
by: Sang Myung Woo
Published: (2017-03-01) -
Excision Repair Cross-Complementation Group 6 Gene Polymorphism Is Associated with the Response to FOLFIRINOX Chemotherapy in Asian Patients with Pancreatic Cancer
by: Young Hoon Choi, et al.
Published: (2021-03-01) -
Clinical outcomes of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions compared with the natural course: a propensity score matching analysis
by: Jin Ho Choi, et al.
Published: (2018-03-01) -
Development of novel biliary metal stent with coil-spring structure and its application in vivo swine biliary stricture model
by: In Rae Cho, et al.
Published: (2023-02-01)